Skip to main content
. 2020 Nov 21;13:100272. doi: 10.1016/j.ynstr.2020.100272

Table 1.

Socio-demographic and clinical characteristics of participants at baseline.

Control group (N = 58) MDD group (baseline, N = 80) Significance
Age (year, mean ± SD) 45.5 ± 12.0 45.4 ± 12.1 t = 0.08
p = 0.93
Gender (female/male) 31/27 47/33 X2 = 0.38 p = 0.53
Educational level (low/high)a 13/45 48/32 X2 = 19.3 p < 0.001**
Age of onset (year, mean ± SD) 36.1 ± 13.2
Number of episodes (%)
First 33.8
Second 32.4
Third or higher 33.8
Early life stress event (% yes)b 10.3 38.0 X2 = 13.18 p < 0.001**
Antidepressant use (%)
None 96.6 4
SSRI 1.7 41
SNRI 0 34
Other (TCA, mirtazapine, bupropion) 1.7 21
Depression severity (HDRS) 0.6 ± 1.3 16.9 ± 5.0 p < 0.001**
Positive affect (PANAS) 36.3 ± 5.6 18.1 ± 5.8 p < 0.001**
Negative affect (PANAS) 14.7 ± 4.2 33.2 ± 8.7 p < 0.001**
Anhedonia (SHAPS) 19.2 ± 4.1 35.7 ± 7.6 p < 0.001**
Neuroticism (NEO-FFI) 3.4 ± 1.6 8.1 ± 1.3 p < 0.001**

P-values are derived from statistical analysis using independent sample t-test for continuous variables or Chi-Square test for categorical variables.

HDRS: Hamilton Rating Scale for Depression; PANAS: Positive and Negative Affect Scale; SHAPS: Snaith¬Hamilton Pleasure Scale; NEO-FFI: NEO-Five Factor Inventory Scale.

a

Low education = finished secondary school or less; High education = any additional education after secondary school.

b

Early life stress event: assessed by Structured Trauma Interview (STI).